Boehringer Ingelheim headquarters. © Boehringer Ingelheim

Boehringer Intelheim is expanding its antfibrotics pipeline licencing a first-in-class treatment for fibro-inflammatory diseases from  Kyowa Kirin Co. Ltd.

Brown and white fat cells. © Patrick Seale, University of Pennsylvania School of Medicine/NIH

Italian Resalis Therapeutics Srl has baged €10m in a Series A financing led by Sunstone Life Science Ventures to complete a Phase I study for RES-010 in obesity.

EM picture of A. baumannii. © Vader1941 - wikipedia.org

Hoffmann-La Roche AG has published details on the mechanism of action of its Phase I antibiotic Zosurabalpin (RG6006) that kills the carbapenem-resistant bug Acinetobacter baumannii.
.

In Berlin-Spandau on the site of the historical Prussian rifle factory from the 19th century, HAVEL LABS is emerging as a Work-Life-Place of the future, precisely tailored to the requirements of companies in the Life Science sector. Picture: © bloomimages

With HAVEL LABS, a unique campus is being developed in Berlin-Spandau. ­Spanning over 20,000 m2, this space is designed for forward-thinking work environments. Modern industrial workplaces and logistics concepts, aligned with GMP (Good Manufacturing Practice) ­guidelines, can be ­effortlessly realised on the premises, as can laboratories ranging from safety level S1 to S3 in ­accordance with German Genetic Engineering Safety Regulations.

Alfasigma manufacturing plant. © N. Biddau/Alfasigma SpA

Following its announcement from Oktober 2023 to take over the filgotinib business from Galapagos NV, Bologna-based Alfasigma SpA has signed the €170m deal.

The “16th European Biotechnology Science & Industry Guide 2026” – the handbook will present the strengths and core competencies of companies and institutions in the fields of Biotech, Biopharma, BioServices and BioManufacturing in Europe. Besides the printed version the guide will also be available as a digital version.

Discovery Center of AstraZeneca @AstraZeneca

Pharmaceutical giant AstrazZeneca wants to take over the Chinese company Gracell Biotechnologies in order to strengthen its cell therapy projects in a deal worth up to $1.2bn.

Picture: Boehmert & Boehmert

The Enlarged Board of Appeal (EBoA) of the European Patent Office will decide upon a question of high relevance for patents in the field biotechnology. The question to be decided concerns the interpretation of what has been “made available to the public”.

The site of the future modern life science campus within easy reach of the city.  Picture: ©?Lukas Görlach

The city is investing in the future by establishing a modern campus and strengthening Mainz as a hub for life sciences. Space with convenient transport connections close to the city centre is available to found or relocate start-ups, companies and research facilities.

In 2021, Metrion Biosciences moved into its labs in Cambridge, UK. © Metrion Biosciences Ltd

Cambridge-based Metrion Biosciences Ltd has secured £3.5m in new equity financing – led by Maven Capital Partners and a £1m contribution from existing investor, Gresham House Ventures.